logo

Stock Screener

Forex Screener

Crypto Screener

CAH

Cardinal Health, Inc. (CAH)

$

149.73

+0.12 (0.08%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

7.7406

Market cap

Market cap

35.8 Billion

Price to sales ratio

Price to sales ratio

0.1606

Debt to equity

Debt to equity

-3.2373

Current ratio

Current ratio

0.9351

Income quality

Income quality

1.5316

Average inventory

Average inventory

16.5 Billion

ROE

ROE

-0.5269



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Cardinal Health, Inc. operates as an integrated healthcare services and products company providing customized solutions across the United States, Canada, Europe, Asia, and other international markets. The company offers tailored services to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home care patients. The company functions in two primary segments: Pharmaceutical and Medical. The Pharmaceutical segment is responsible for distributing both branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products. Additionally, it supports pharmaceutical manufacturers and healthcare providers through various services linked to specialty pharmaceuticals; manages nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic and over-the-counter healthcare products; and delivers medication therapy management and patient outcomes services to hospitals, healthcare providers, and payers. The operational income ratio is 0.01 indicating the company's operational profitability margin, while the company recorded an operating income of $2,275,000,000.00 reflecting its earnings from core operations. The income before tax ratio stands at 0.01 which shows the pre-tax margin. On the stock market, the company’s stock is identified with the symbol 'CAH', and the gross profit is $8,168,000,000.00 highlighting the company's profitability from its core operations. Conversely, the Medical segment involves the manufacture, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products, along with a comprehensive range of solutions for healthcare providers. The stock is reasonably priced at $161.69 appealing to a broad array of investors. With a high average trading volume of 2,190,900.00 it demonstrates strong liquidity in the market. The company boasts a mid-range market capitalization of $35,754,625,620.00 positioning it as a steady performer within the industry. As a key player in the Medical - Distribution industry, Cardinal Health significantly contributes to the overall market landscape and embraces its role in driving innovation and growth as part of the Healthcare sector. The combination of a robust product portfolio, strategic market presence, and solid financial metrics underlines the company's commitment to delivering effective healthcare solutions.

What is Cardinal Health, Inc. (CAH)'s current stock price?

The current stock price of Cardinal Health, Inc. (CAH) is $148.94 as of 2025-08-19. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Cardinal Health, Inc. (CAH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Cardinal Health, Inc. stock to fluctuate between $106.54 (low) and $168.44 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-19, Cardinal Health, Inc.'s market cap is $35,754,625,620, based on 238,794,000 outstanding shares.

Compared to Eli Lilly & Co., Cardinal Health, Inc. has a Lower Market-Cap, indicating a difference in performance.

Cardinal Health, Inc. pays dividends. The current dividend yield is 1.37%, with a payout of $0.51 per share.

To buy Cardinal Health, Inc. (CAH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAH. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Cardinal Health, Inc.'s last stock split was 3:2 on 2001-04-23.

Revenue: $222,578,000,000 | EPS: $6.48 | Growth: 86.21%.

Visit https://www.cardinalhealth.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $168.44 (2025-07-01) | All-time low: $45.85 (2021-12-01).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CAH

zacks.com

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

CAH

zacks.com

All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy

Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CAH

zacks.com

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CAH

prnewswire.com

Cardinal Health Board of Directors Approves Quarterly Dividend

DUBLIN, Ohio , Aug. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2025 to shareholders of record at the close of business on October 1, 2025.

CAH

zacks.com

Cardinal Health to Acquire Solaris Health for Urology Expansion

CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.

CAH

zacks.com

After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)

The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CAH

fool.com

Why Cardinal Health Stock Was Tumbling on Tuesday

Sprawling healthcare company Cardinal Health (CAH -7.08%) reported its latest quarterly results and announced a sizable new acquisition Tuesday morning. The market didn't take these news items well, however, and in late-session trading, it was pushing the company's share price down by nearly 7%.

CAH

zacks.com

Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CAH

pymnts.com

Cardinal Health to Extend Reach by Acquiring Solaris Health

Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing about $1.9 billion in cash to The Specialty Alliance and will own about 75% of The Specialty Alliance after the acquisition of Solaris Health, Cardinal Health said in a Tuesday (Aug.

CAH

zacks.com

CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls

Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener